Making sense of agreement among interferon-gamma release assays and tuberculosis skin testing

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 2, 2008, Pages 152-159

  Davidow, Amy L ^a   Affouf, M ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KEAN UNIVERSITY   (United States)

Author keywords

Interferon gamma release assays; Kappa agreement; Latent tuberculosis infection

Indexed keywords

GAMMA INTERFERON;

ARTICLE; ENZYME LINKED IMMUNOSPOT ASSAY; MATHEMATICAL MODEL; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

HUMANS; INTERFERON TYPE II; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 38949187147     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49: 1-51.
2. Bearman J E. A study of the variability in tuberculin test reading. Am Rev Respir Dis 1964; 90: 913-919.
3. Malotte C K, Hollingshead J R, Rhodes F. Monetary versus non-monetary incentives for TB skin test reading among drug users. Am J Prev Med 1999; 16: 182-188.
4. Graham N M, Nelson K E, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA 1992; 267: 369-373.
5. Snider D E Jr. Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA 1985; 253: 3438-3439.
6. Huebner R E, Schein M F, Cauthen G M, et al. Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses. Am Rev Respir Dis 1992; 145: 1160-1166.
7. Rothel J S, Jones S L, Corner L A, Cox J C, Wood P R. A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J 1990; 67: 134-137.
8. Andersen P, Munk M E, Pollock J M, Doherty T M. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
9. Lalvani A, Pathan A A, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T-cells. Am J Respir Crit Care Med 2001; 163: 824-828.
10. Arend S M, Engelhard A C, Groot G, et al. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diagn Lab Immunol 2001; 8: 1089-1096.
11. Codecasa L, Mantegani P, Galli L, Lazzarin A, Scarpellini P, Fortis C. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. J Clin Microbiol 2006; 44: 1944-1950.
12. Pai M, Riley L W, Colford J M. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
13. Cohen J. A coefficient of agreement for nominal scales. Educational Psychol Measurement 1960; 20: 37-46.
14. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
15. Harboe M, Oettinger T, Wiker H G, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16-22.
16. Thompson W D, Walter S D. A reappraisal of the kappa coefficient. J Clin Epidemiol 1988; 41: 949-958.
17. Mazurek G H, LoBue P A, Daley C L, et al. Comparison of whole-blood interferon-γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
18. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
19. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170: 65-69.
20. Hill P C, Brookes R H, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38: 966-973.
21. Lowry R. Kappa as a measure of concordance in categorical sorting. http://Faculty.vassar.edu/lowry/VassarStats.html Accessed 21 September 2007.
22. Arend S M, Thijsen S F T, Leyten E M S, et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-627.
23. Mazurek G H, Jereb J, Lobue P, Iademarco M F, Metchock B, Vernon A. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
24. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349-355.